Treatment Continuity Act of 2025
- Bill Number
- H.R. 4030
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-06-17: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2025-10-07T08:05:36Z
AI-Generated Summary
Purpose The Treatment Continuity Act of 2025 amends the Public Health Service Act to let the Secretary of Health and Human Services use grants to improve access to long-acting injectable medications for treating substance use disorders and serious mental illness, along with related testing, counseling, and provider training.
Key Provisions
- Updates Section 509 to cover both substance use disorder and serious mental illness.
- Authorizes grants for:
- Access to FDA-approved long-acting injectable medications.
- Lab testing and supportive counseling.
- Training for providers on using these medications with clinical services.
- Requires the Secretary to submit an annual report to Congress on program outcomes, including progress toward treatment goals based on clinician assessments.
- Applies the new rules to grants awarded after the bill’s enactment.
Significant Changes to Existing Law
- Expands the original focus of Section 509 from substance use disorder alone to also include serious mental illness.
- Replaces prior grant priorities with specific emphasis on long-acting injectable medications and associated services.
- Adds a new annual reporting requirement to Congress and removes two existing subsections.
Potential Impacts
- Government agencies: Increases responsibilities for the Department of Health and Human Services in administering grants and reporting.
- Citizens: May improve treatment access and continuity for people with substance use disorders or serious mental illness.
- No direct effects on international relations are outlined.
Main Stakeholders Affected
- Individuals with substance use disorders or serious mental illness.
- Healthcare providers and organizations receiving grants.
- The Department of Health and Human Services.
- Congress (through required annual reports).
Notable Legal, Constitutional, or Political Implications The bill makes targeted changes to existing public health grant authority with no apparent constitutional conflicts or major legal barriers identified in the text. It reflects a policy emphasis on medication-assisted treatment for mental health and addiction without altering core federal-state relationships.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Rep. Soto, Darren [D-FL-9], Rep. Bean, Aaron [R-FL-4], Rep. Vindman, Eugene Simon [D-VA-7]
Recent Actions
- 2025-06-17: Referred to the House Committee on Energy and Commerce.
- 2025-06-17: Introduced in House
- 2025-06-17: Introduced in House
Bill Versions
- Treatment Continuity Act of 2025 — issued 2025-06-17 — PDF (3 pages)